Inovio Pharmaceuticals Inc (INO)

[pistol1p]

Over the last two years we have seen many positives surrounding INO, pushing the pps from $.50 to $4.00 pre-reverse split.

The positive price moves that follow news are often followed by an extended period of no news or dilution or the announcement of dilution. Without anything current news, and/or communication the pps erodes.

As someone earlier stated, flipping shares after the positive news, has been the most profitable way to play INO. This pattern has been played out a number of times in the last two years.

Will or have the long term longs made money? Many have, but to attract new long term retail shareholders, the pps will have to be more stable. More communication by management as to why the positive phase 2 data was follow immediately by the shelf registration.

If management continues to disregard the effective of their behavior and decisions the pps, INO stock will continue to subject to manipulation and an inability to hold any legitimate gains.